nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—SCN4B—myometrium—ovarian cancer	0.00842	0.029	CbGeAlD
Zonisamide—CA11—myometrium—ovarian cancer	0.00725	0.0249	CbGeAlD
Zonisamide—CA8—endometrium—ovarian cancer	0.0071	0.0244	CbGeAlD
Zonisamide—SCN4B—uterine cervix—ovarian cancer	0.00656	0.0225	CbGeAlD
Zonisamide—SCN1B—female reproductive system—ovarian cancer	0.00626	0.0215	CbGeAlD
Zonisamide—CA10—female reproductive system—ovarian cancer	0.006	0.0206	CbGeAlD
Zonisamide—CA11—uterine cervix—ovarian cancer	0.00564	0.0194	CbGeAlD
Zonisamide—CA11—decidua—ovarian cancer	0.00538	0.0185	CbGeAlD
Zonisamide—SCN3B—vagina—ovarian cancer	0.00522	0.018	CbGeAlD
Zonisamide—CA11—endometrium—ovarian cancer	0.0051	0.0175	CbGeAlD
Zonisamide—SCN1B—testis—ovarian cancer	0.00505	0.0174	CbGeAlD
Zonisamide—CA10—testis—ovarian cancer	0.00484	0.0166	CbGeAlD
Zonisamide—CA8—testis—ovarian cancer	0.00475	0.0163	CbGeAlD
Zonisamide—CA11—uterus—ovarian cancer	0.0047	0.0162	CbGeAlD
Zonisamide—SCN3B—testis—ovarian cancer	0.00466	0.016	CbGeAlD
Zonisamide—CA13—female gonad—ovarian cancer	0.00458	0.0158	CbGeAlD
Zonisamide—CA13—vagina—ovarian cancer	0.00455	0.0157	CbGeAlD
Zonisamide—SCN4B—vagina—ovarian cancer	0.00444	0.0153	CbGeAlD
Zonisamide—CA3—myometrium—ovarian cancer	0.00443	0.0152	CbGeAlD
Zonisamide—CA5A—female reproductive system—ovarian cancer	0.00423	0.0145	CbGeAlD
Zonisamide—CA11—female reproductive system—ovarian cancer	0.00423	0.0145	CbGeAlD
Zonisamide—CACNA1G—decidua—ovarian cancer	0.00418	0.0144	CbGeAlD
Zonisamide—CA13—testis—ovarian cancer	0.00406	0.014	CbGeAlD
Zonisamide—CA11—bone marrow—ovarian cancer	0.00399	0.0137	CbGeAlD
Zonisamide—SCN4B—testis—ovarian cancer	0.00396	0.0136	CbGeAlD
Zonisamide—CACNA1I—testis—ovarian cancer	0.00387	0.0133	CbGeAlD
Zonisamide—CA11—female gonad—ovarian cancer	0.00385	0.0132	CbGeAlD
Zonisamide—CA11—vagina—ovarian cancer	0.00382	0.0131	CbGeAlD
Zonisamide—CACNA1H—myometrium—ovarian cancer	0.00369	0.0127	CbGeAlD
Zonisamide—SCN1B—lymph node—ovarian cancer	0.00366	0.0126	CbGeAlD
Zonisamide—CA3—uterine cervix—ovarian cancer	0.00344	0.0118	CbGeAlD
Zonisamide—CA8—lymph node—ovarian cancer	0.00344	0.0118	CbGeAlD
Zonisamide—CA11—testis—ovarian cancer	0.00341	0.0117	CbGeAlD
Zonisamide—SCN3B—lymph node—ovarian cancer	0.00338	0.0116	CbGeAlD
Zonisamide—CA13—lymph node—ovarian cancer	0.00295	0.0101	CbGeAlD
Zonisamide—SCN4B—lymph node—ovarian cancer	0.00287	0.00988	CbGeAlD
Zonisamide—CA3—uterus—ovarian cancer	0.00287	0.00987	CbGeAlD
Zonisamide—CACNA1I—lymph node—ovarian cancer	0.00281	0.00965	CbGeAlD
Zonisamide—AOX1—myometrium—ovarian cancer	0.00261	0.00899	CbGeAlD
Zonisamide—CA11—lymph node—ovarian cancer	0.00247	0.0085	CbGeAlD
Zonisamide—CA9—female reproductive system—ovarian cancer	0.00247	0.00849	CbGeAlD
Zonisamide—CA3—bone marrow—ovarian cancer	0.00244	0.00837	CbGeAlD
Zonisamide—CACNA1H—gonad—ovarian cancer	0.00241	0.00828	CbGeAlD
Zonisamide—CACNA1H—uterus—ovarian cancer	0.00239	0.00822	CbGeAlD
Zonisamide—CA3—vagina—ovarian cancer	0.00233	0.00802	CbGeAlD
Zonisamide—CACNA1H—female reproductive system—ovarian cancer	0.00215	0.00739	CbGeAlD
Zonisamide—CA3—testis—ovarian cancer	0.00208	0.00716	CbGeAlD
Zonisamide—AOX1—uterine cervix—ovarian cancer	0.00203	0.00699	CbGeAlD
Zonisamide—SCN3A—decidua—ovarian cancer	0.00203	0.00696	CbGeAlD
Zonisamide—MAOB—myometrium—ovarian cancer	0.00201	0.00692	CbGeAlD
Zonisamide—CA9—testis—ovarian cancer	0.00199	0.00685	CbGeAlD
Zonisamide—CACNA1H—female gonad—ovarian cancer	0.00196	0.00673	CbGeAlD
Zonisamide—AOX1—decidua—ovarian cancer	0.00194	0.00666	CbGeAlD
Zonisamide—MAOB—embryo—ovarian cancer	0.00194	0.00666	CbGeAlD
Zonisamide—SCN9A—testis—ovarian cancer	0.00185	0.00637	CbGeAlD
Zonisamide—AOX1—endometrium—ovarian cancer	0.00184	0.00633	CbGeAlD
Zonisamide—CA5B—gonad—ovarian cancer	0.00184	0.00631	CbGeAlD
Zonisamide—CA12—female reproductive system—ovarian cancer	0.00183	0.00628	CbGeAlD
Zonisamide—CACNA1H—testis—ovarian cancer	0.00174	0.00597	CbGeAlD
Zonisamide—MAOA—myometrium—ovarian cancer	0.00172	0.00591	CbGeAlD
Zonisamide—AOX1—gonad—ovarian cancer	0.00171	0.00587	CbGeAlD
Zonisamide—AOX1—uterus—ovarian cancer	0.0017	0.00583	CbGeAlD
Zonisamide—MAOA—embryo—ovarian cancer	0.00165	0.00568	CbGeAlD
Zonisamide—SCN4A—testis—ovarian cancer	0.00165	0.00568	CbGeAlD
Zonisamide—SCN2A—vagina—ovarian cancer	0.00164	0.00563	CbGeAlD
Zonisamide—CA5B—female reproductive system—ovarian cancer	0.00164	0.00563	CbGeAlD
Zonisamide—SCN3A—female reproductive system—ovarian cancer	0.00159	0.00548	CbGeAlD
Zonisamide—MAOB—uterine cervix—ovarian cancer	0.00157	0.00539	CbGeAlD
Zonisamide—CA2—embryo—ovarian cancer	0.00155	0.00532	CbGeAlD
Zonisamide—AOX1—female reproductive system—ovarian cancer	0.00152	0.00524	CbGeAlD
Zonisamide—CA3—lymph node—ovarian cancer	0.00151	0.00519	CbGeAlD
Zonisamide—SCN3A—bone marrow—ovarian cancer	0.0015	0.00517	CbGeAlD
Zonisamide—MAOB—decidua—ovarian cancer	0.00149	0.00513	CbGeAlD
Zonisamide—CA5B—vagina—ovarian cancer	0.00148	0.0051	CbGeAlD
Zonisamide—CA1—female reproductive system—ovarian cancer	0.00145	0.00498	CbGeAlD
Zonisamide—SCN3A—vagina—ovarian cancer	0.00144	0.00495	CbGeAlD
Zonisamide—SCN5A—vagina—ovarian cancer	0.00144	0.00494	CbGeAlD
Zonisamide—MAOB—endometrium—ovarian cancer	0.00142	0.00487	CbGeAlD
Zonisamide—AOX1—female gonad—ovarian cancer	0.00139	0.00477	CbGeAlD
Zonisamide—AOX1—vagina—ovarian cancer	0.00138	0.00474	CbGeAlD
Zonisamide—CA1—bone marrow—ovarian cancer	0.00137	0.0047	CbGeAlD
Zonisamide—SCN9A—lymph node—ovarian cancer	0.00134	0.00462	CbGeAlD
Zonisamide—MAOA—uterine cervix—ovarian cancer	0.00134	0.0046	CbGeAlD
Zonisamide—CA5B—testis—ovarian cancer	0.00132	0.00455	CbGeAlD
Zonisamide—MAOB—uterus—ovarian cancer	0.00131	0.00449	CbGeAlD
Zonisamide—SCN3A—testis—ovarian cancer	0.00129	0.00442	CbGeAlD
Zonisamide—MAOA—decidua—ovarian cancer	0.00127	0.00438	CbGeAlD
Zonisamide—CA2—epithelium—ovarian cancer	0.00126	0.00434	CbGeAlD
Zonisamide—CACNA1H—lymph node—ovarian cancer	0.00126	0.00433	CbGeAlD
Zonisamide—AOX1—testis—ovarian cancer	0.00123	0.00423	CbGeAlD
Zonisamide—MAOA—endometrium—ovarian cancer	0.00121	0.00416	CbGeAlD
Zonisamide—CA2—decidua—ovarian cancer	0.00119	0.0041	CbGeAlD
Zonisamide—MAOB—female reproductive system—ovarian cancer	0.00117	0.00404	CbGeAlD
Zonisamide—CA4—female reproductive system—ovarian cancer	0.00113	0.00389	CbGeAlD
Zonisamide—MAOA—uterus—ovarian cancer	0.00111	0.00383	CbGeAlD
Zonisamide—MAOB—female gonad—ovarian cancer	0.00107	0.00367	CbGeAlD
Zonisamide—CA4—bone marrow—ovarian cancer	0.00107	0.00367	CbGeAlD
Zonisamide—MAOB—vagina—ovarian cancer	0.00106	0.00365	CbGeAlD
Zonisamide—CA4—female gonad—ovarian cancer	0.00103	0.00354	CbGeAlD
Zonisamide—MAOA—female reproductive system—ovarian cancer	0.001	0.00344	CbGeAlD
Zonisamide—CA5B—lymph node—ovarian cancer	0.000959	0.0033	CbGeAlD
Zonisamide—MAOB—testis—ovarian cancer	0.000948	0.00326	CbGeAlD
Zonisamide—CA2—female reproductive system—ovarian cancer	0.000938	0.00322	CbGeAlD
Zonisamide—SCN3A—lymph node—ovarian cancer	0.000932	0.0032	CbGeAlD
Zonisamide—CYP2C19—vagina—ovarian cancer	0.000926	0.00318	CbGeAlD
Zonisamide—CA4—testis—ovarian cancer	0.000913	0.00314	CbGeAlD
Zonisamide—MAOA—female gonad—ovarian cancer	0.000912	0.00313	CbGeAlD
Zonisamide—MAOA—vagina—ovarian cancer	0.000906	0.00312	CbGeAlD
Zonisamide—AOX1—lymph node—ovarian cancer	0.000892	0.00307	CbGeAlD
Zonisamide—CA2—bone marrow—ovarian cancer	0.000886	0.00304	CbGeAlD
Zonisamide—CA2—female gonad—ovarian cancer	0.000854	0.00293	CbGeAlD
Zonisamide—CA2—vagina—ovarian cancer	0.000848	0.00292	CbGeAlD
Zonisamide—CA1—lymph node—ovarian cancer	0.000847	0.00291	CbGeAlD
Zonisamide—MAOA—testis—ovarian cancer	0.000809	0.00278	CbGeAlD
Zonisamide—CA2—testis—ovarian cancer	0.000757	0.0026	CbGeAlD
Zonisamide—MAOB—lymph node—ovarian cancer	0.000687	0.00236	CbGeAlD
Zonisamide—CA4—lymph node—ovarian cancer	0.000662	0.00227	CbGeAlD
Zonisamide—CYP3A4—female reproductive system—ovarian cancer	0.000605	0.00208	CbGeAlD
Zonisamide—MAOA—lymph node—ovarian cancer	0.000586	0.00202	CbGeAlD
Zonisamide—CA2—lymph node—ovarian cancer	0.000549	0.00189	CbGeAlD
Zonisamide—Palpitations—Docetaxel—ovarian cancer	0.00032	0.000636	CcSEcCtD
Zonisamide—Weight increased—Epirubicin—ovarian cancer	0.000319	0.000634	CcSEcCtD
Zonisamide—Loss of consciousness—Docetaxel—ovarian cancer	0.000318	0.000633	CcSEcCtD
Zonisamide—Pancreatitis—Doxorubicin—ovarian cancer	0.000318	0.000632	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000317	0.000631	CcSEcCtD
Zonisamide—Weight decreased—Epirubicin—ovarian cancer	0.000317	0.00063	CcSEcCtD
Zonisamide—Cough—Docetaxel—ovarian cancer	0.000316	0.000628	CcSEcCtD
Zonisamide—Insomnia—Paclitaxel—ovarian cancer	0.000315	0.000627	CcSEcCtD
Zonisamide—Pneumonia—Epirubicin—ovarian cancer	0.000314	0.000625	CcSEcCtD
Zonisamide—Convulsion—Docetaxel—ovarian cancer	0.000313	0.000624	CcSEcCtD
Zonisamide—Paraesthesia—Paclitaxel—ovarian cancer	0.000313	0.000622	CcSEcCtD
Zonisamide—Hypertension—Docetaxel—ovarian cancer	0.000312	0.000621	CcSEcCtD
Zonisamide—Dyspnoea—Paclitaxel—ovarian cancer	0.00031	0.000618	CcSEcCtD
Zonisamide—Somnolence—Paclitaxel—ovarian cancer	0.00031	0.000616	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000309	0.000616	CcSEcCtD
Zonisamide—Chest pain—Docetaxel—ovarian cancer	0.000308	0.000613	CcSEcCtD
Zonisamide—Myalgia—Docetaxel—ovarian cancer	0.000308	0.000613	CcSEcCtD
Zonisamide—Arthralgia—Docetaxel—ovarian cancer	0.000308	0.000613	CcSEcCtD
Zonisamide—Pancytopenia—Doxorubicin—ovarian cancer	0.000308	0.000612	CcSEcCtD
Zonisamide—Nausea—Vinorelbine—ovarian cancer	0.000307	0.000612	CcSEcCtD
Zonisamide—Renal failure—Epirubicin—ovarian cancer	0.000307	0.000611	CcSEcCtD
Zonisamide—Dyspepsia—Paclitaxel—ovarian cancer	0.000306	0.00061	CcSEcCtD
Zonisamide—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000306	0.000609	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000306	0.000609	CcSEcCtD
Zonisamide—Stomatitis—Epirubicin—ovarian cancer	0.000304	0.000606	CcSEcCtD
Zonisamide—Conjunctivitis—Epirubicin—ovarian cancer	0.000303	0.000604	CcSEcCtD
Zonisamide—Urinary tract infection—Epirubicin—ovarian cancer	0.000303	0.000604	CcSEcCtD
Zonisamide—Dysuria—Doxorubicin—ovarian cancer	0.000303	0.000603	CcSEcCtD
Zonisamide—Decreased appetite—Paclitaxel—ovarian cancer	0.000303	0.000602	CcSEcCtD
Zonisamide—Dry mouth—Docetaxel—ovarian cancer	0.000301	0.000599	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000301	0.000598	CcSEcCtD
Zonisamide—Fatigue—Paclitaxel—ovarian cancer	0.0003	0.000597	CcSEcCtD
Zonisamide—Sweating—Epirubicin—ovarian cancer	0.000299	0.000596	CcSEcCtD
Zonisamide—Pollakiuria—Doxorubicin—ovarian cancer	0.000299	0.000596	CcSEcCtD
Zonisamide—Constipation—Paclitaxel—ovarian cancer	0.000298	0.000593	CcSEcCtD
Zonisamide—Haematuria—Epirubicin—ovarian cancer	0.000298	0.000592	CcSEcCtD
Zonisamide—Confusional state—Docetaxel—ovarian cancer	0.000298	0.000592	CcSEcCtD
Zonisamide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000295	0.000588	CcSEcCtD
Zonisamide—Oedema—Docetaxel—ovarian cancer	0.000295	0.000587	CcSEcCtD
Zonisamide—Weight increased—Doxorubicin—ovarian cancer	0.000295	0.000587	CcSEcCtD
Zonisamide—Infection—Docetaxel—ovarian cancer	0.000293	0.000584	CcSEcCtD
Zonisamide—Weight decreased—Doxorubicin—ovarian cancer	0.000293	0.000583	CcSEcCtD
Zonisamide—Agranulocytosis—Epirubicin—ovarian cancer	0.000291	0.00058	CcSEcCtD
Zonisamide—Pneumonia—Doxorubicin—ovarian cancer	0.00029	0.000578	CcSEcCtD
Zonisamide—Shock—Docetaxel—ovarian cancer	0.00029	0.000578	CcSEcCtD
Zonisamide—Nervous system disorder—Docetaxel—ovarian cancer	0.000289	0.000576	CcSEcCtD
Zonisamide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000289	0.000575	CcSEcCtD
Zonisamide—Tachycardia—Docetaxel—ovarian cancer	0.000288	0.000573	CcSEcCtD
Zonisamide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000287	0.000571	CcSEcCtD
Zonisamide—Skin disorder—Docetaxel—ovarian cancer	0.000287	0.000571	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000286	0.00057	CcSEcCtD
Zonisamide—Bradycardia—Epirubicin—ovarian cancer	0.000285	0.000568	CcSEcCtD
Zonisamide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000285	0.000567	CcSEcCtD
Zonisamide—Renal failure—Doxorubicin—ovarian cancer	0.000284	0.000565	CcSEcCtD
Zonisamide—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000283	0.000563	CcSEcCtD
Zonisamide—Stomatitis—Doxorubicin—ovarian cancer	0.000281	0.00056	CcSEcCtD
Zonisamide—Anorexia—Docetaxel—ovarian cancer	0.000281	0.00056	CcSEcCtD
Zonisamide—Rhinitis—Epirubicin—ovarian cancer	0.000281	0.000559	CcSEcCtD
Zonisamide—Conjunctivitis—Doxorubicin—ovarian cancer	0.000281	0.000559	CcSEcCtD
Zonisamide—Urinary tract infection—Doxorubicin—ovarian cancer	0.000281	0.000559	CcSEcCtD
Zonisamide—Pharyngitis—Epirubicin—ovarian cancer	0.000278	0.000553	CcSEcCtD
Zonisamide—Sweating—Doxorubicin—ovarian cancer	0.000277	0.000551	CcSEcCtD
Zonisamide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000277	0.000551	CcSEcCtD
Zonisamide—Urticaria—Paclitaxel—ovarian cancer	0.000277	0.000551	CcSEcCtD
Zonisamide—Oedema peripheral—Epirubicin—ovarian cancer	0.000276	0.000549	CcSEcCtD
Zonisamide—Hypotension—Docetaxel—ovarian cancer	0.000276	0.000549	CcSEcCtD
Zonisamide—Haematuria—Doxorubicin—ovarian cancer	0.000275	0.000548	CcSEcCtD
Zonisamide—Connective tissue disorder—Epirubicin—ovarian cancer	0.000275	0.000548	CcSEcCtD
Zonisamide—Body temperature increased—Paclitaxel—ovarian cancer	0.000275	0.000548	CcSEcCtD
Zonisamide—Abdominal pain—Paclitaxel—ovarian cancer	0.000275	0.000548	CcSEcCtD
Zonisamide—Urethral disorder—Epirubicin—ovarian cancer	0.000275	0.000547	CcSEcCtD
Zonisamide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000273	0.000544	CcSEcCtD
Zonisamide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000269	0.000536	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000269	0.000535	CcSEcCtD
Zonisamide—Insomnia—Docetaxel—ovarian cancer	0.000267	0.000531	CcSEcCtD
Zonisamide—Paraesthesia—Docetaxel—ovarian cancer	0.000265	0.000527	CcSEcCtD
Zonisamide—Erythema multiforme—Epirubicin—ovarian cancer	0.000265	0.000527	CcSEcCtD
Zonisamide—Bradycardia—Doxorubicin—ovarian cancer	0.000264	0.000525	CcSEcCtD
Zonisamide—Dyspnoea—Docetaxel—ovarian cancer	0.000263	0.000524	CcSEcCtD
Zonisamide—Somnolence—Docetaxel—ovarian cancer	0.000262	0.000522	CcSEcCtD
Zonisamide—Eye disorder—Epirubicin—ovarian cancer	0.000262	0.000521	CcSEcCtD
Zonisamide—Tinnitus—Epirubicin—ovarian cancer	0.000261	0.00052	CcSEcCtD
Zonisamide—Rhinitis—Doxorubicin—ovarian cancer	0.00026	0.000517	CcSEcCtD
Zonisamide—Dyspepsia—Docetaxel—ovarian cancer	0.00026	0.000517	CcSEcCtD
Zonisamide—Pharyngitis—Doxorubicin—ovarian cancer	0.000257	0.000512	CcSEcCtD
Zonisamide—Decreased appetite—Docetaxel—ovarian cancer	0.000257	0.000511	CcSEcCtD
Zonisamide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000257	0.000511	CcSEcCtD
Zonisamide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000256	0.00051	CcSEcCtD
Zonisamide—Oedema peripheral—Doxorubicin—ovarian cancer	0.000255	0.000508	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000255	0.000507	CcSEcCtD
Zonisamide—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000255	0.000507	CcSEcCtD
Zonisamide—Fatigue—Docetaxel—ovarian cancer	0.000254	0.000506	CcSEcCtD
Zonisamide—Urethral disorder—Doxorubicin—ovarian cancer	0.000254	0.000506	CcSEcCtD
Zonisamide—Immune system disorder—Epirubicin—ovarian cancer	0.000253	0.000504	CcSEcCtD
Zonisamide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000252	0.000503	CcSEcCtD
Zonisamide—Constipation—Docetaxel—ovarian cancer	0.000252	0.000502	CcSEcCtD
Zonisamide—Asthenia—Paclitaxel—ovarian cancer	0.00025	0.000497	CcSEcCtD
Zonisamide—Alopecia—Epirubicin—ovarian cancer	0.000248	0.000493	CcSEcCtD
Zonisamide—Pruritus—Paclitaxel—ovarian cancer	0.000246	0.00049	CcSEcCtD
Zonisamide—Mental disorder—Epirubicin—ovarian cancer	0.000245	0.000489	CcSEcCtD
Zonisamide—Erythema multiforme—Doxorubicin—ovarian cancer	0.000245	0.000488	CcSEcCtD
Zonisamide—Malnutrition—Epirubicin—ovarian cancer	0.000244	0.000485	CcSEcCtD
Zonisamide—Feeling abnormal—Docetaxel—ovarian cancer	0.000243	0.000484	CcSEcCtD
Zonisamide—Eye disorder—Doxorubicin—ovarian cancer	0.000242	0.000482	CcSEcCtD
Zonisamide—Tinnitus—Doxorubicin—ovarian cancer	0.000242	0.000481	CcSEcCtD
Zonisamide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000241	0.00048	CcSEcCtD
Zonisamide—Flatulence—Epirubicin—ovarian cancer	0.00024	0.000478	CcSEcCtD
Zonisamide—Tension—Epirubicin—ovarian cancer	0.000239	0.000476	CcSEcCtD
Zonisamide—Dysgeusia—Epirubicin—ovarian cancer	0.000239	0.000475	CcSEcCtD
Zonisamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000238	0.000474	CcSEcCtD
Zonisamide—Nervousness—Epirubicin—ovarian cancer	0.000237	0.000472	CcSEcCtD
Zonisamide—Muscle spasms—Epirubicin—ovarian cancer	0.000234	0.000467	CcSEcCtD
Zonisamide—Immune system disorder—Doxorubicin—ovarian cancer	0.000234	0.000466	CcSEcCtD
Zonisamide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000234	0.000465	CcSEcCtD
Zonisamide—Abdominal pain—Docetaxel—ovarian cancer	0.000233	0.000464	CcSEcCtD
Zonisamide—Body temperature increased—Docetaxel—ovarian cancer	0.000233	0.000464	CcSEcCtD
Zonisamide—Dizziness—Paclitaxel—ovarian cancer	0.00023	0.000458	CcSEcCtD
Zonisamide—Alopecia—Doxorubicin—ovarian cancer	0.000229	0.000456	CcSEcCtD
Zonisamide—Mental disorder—Doxorubicin—ovarian cancer	0.000227	0.000452	CcSEcCtD
Zonisamide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000226	0.00045	CcSEcCtD
Zonisamide—Malnutrition—Doxorubicin—ovarian cancer	0.000226	0.000449	CcSEcCtD
Zonisamide—Anaemia—Epirubicin—ovarian cancer	0.000225	0.000449	CcSEcCtD
Zonisamide—Agitation—Epirubicin—ovarian cancer	0.000224	0.000446	CcSEcCtD
Zonisamide—Flatulence—Doxorubicin—ovarian cancer	0.000222	0.000443	CcSEcCtD
Zonisamide—Tension—Doxorubicin—ovarian cancer	0.000221	0.000441	CcSEcCtD
Zonisamide—Vomiting—Paclitaxel—ovarian cancer	0.000221	0.000441	CcSEcCtD
Zonisamide—Dysgeusia—Doxorubicin—ovarian cancer	0.000221	0.00044	CcSEcCtD
Zonisamide—Malaise—Epirubicin—ovarian cancer	0.00022	0.000438	CcSEcCtD
Zonisamide—Rash—Paclitaxel—ovarian cancer	0.00022	0.000437	CcSEcCtD
Zonisamide—Dermatitis—Paclitaxel—ovarian cancer	0.000219	0.000437	CcSEcCtD
Zonisamide—Nervousness—Doxorubicin—ovarian cancer	0.000219	0.000436	CcSEcCtD
Zonisamide—Vertigo—Epirubicin—ovarian cancer	0.000219	0.000436	CcSEcCtD
Zonisamide—Syncope—Epirubicin—ovarian cancer	0.000219	0.000435	CcSEcCtD
Zonisamide—Leukopenia—Epirubicin—ovarian cancer	0.000218	0.000435	CcSEcCtD
Zonisamide—Headache—Paclitaxel—ovarian cancer	0.000218	0.000434	CcSEcCtD
Zonisamide—Hypersensitivity—Docetaxel—ovarian cancer	0.000217	0.000433	CcSEcCtD
Zonisamide—Muscle spasms—Doxorubicin—ovarian cancer	0.000217	0.000432	CcSEcCtD
Zonisamide—Palpitations—Epirubicin—ovarian cancer	0.000216	0.000429	CcSEcCtD
Zonisamide—Loss of consciousness—Epirubicin—ovarian cancer	0.000214	0.000427	CcSEcCtD
Zonisamide—Cough—Epirubicin—ovarian cancer	0.000213	0.000424	CcSEcCtD
Zonisamide—Asthenia—Docetaxel—ovarian cancer	0.000212	0.000421	CcSEcCtD
Zonisamide—Convulsion—Epirubicin—ovarian cancer	0.000211	0.000421	CcSEcCtD
Zonisamide—Hypertension—Epirubicin—ovarian cancer	0.000211	0.000419	CcSEcCtD
Zonisamide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000209	0.000417	CcSEcCtD
Zonisamide—Pruritus—Docetaxel—ovarian cancer	0.000209	0.000416	CcSEcCtD
Zonisamide—Anaemia—Doxorubicin—ovarian cancer	0.000209	0.000415	CcSEcCtD
Zonisamide—Chest pain—Epirubicin—ovarian cancer	0.000208	0.000413	CcSEcCtD
Zonisamide—Myalgia—Epirubicin—ovarian cancer	0.000208	0.000413	CcSEcCtD
Zonisamide—Arthralgia—Epirubicin—ovarian cancer	0.000208	0.000413	CcSEcCtD
Zonisamide—Agitation—Doxorubicin—ovarian cancer	0.000207	0.000413	CcSEcCtD
Zonisamide—Anxiety—Epirubicin—ovarian cancer	0.000207	0.000412	CcSEcCtD
Zonisamide—Nausea—Paclitaxel—ovarian cancer	0.000207	0.000412	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000206	0.00041	CcSEcCtD
Zonisamide—Discomfort—Epirubicin—ovarian cancer	0.000205	0.000408	CcSEcCtD
Zonisamide—Malaise—Doxorubicin—ovarian cancer	0.000203	0.000405	CcSEcCtD
Zonisamide—Dry mouth—Epirubicin—ovarian cancer	0.000203	0.000404	CcSEcCtD
Zonisamide—Vertigo—Doxorubicin—ovarian cancer	0.000203	0.000404	CcSEcCtD
Zonisamide—Syncope—Doxorubicin—ovarian cancer	0.000202	0.000403	CcSEcCtD
Zonisamide—Leukopenia—Doxorubicin—ovarian cancer	0.000202	0.000402	CcSEcCtD
Zonisamide—Diarrhoea—Docetaxel—ovarian cancer	0.000202	0.000402	CcSEcCtD
Zonisamide—Confusional state—Epirubicin—ovarian cancer	0.000201	0.000399	CcSEcCtD
Zonisamide—Palpitations—Doxorubicin—ovarian cancer	0.000199	0.000397	CcSEcCtD
Zonisamide—Oedema—Epirubicin—ovarian cancer	0.000199	0.000396	CcSEcCtD
Zonisamide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000198	0.000395	CcSEcCtD
Zonisamide—Infection—Epirubicin—ovarian cancer	0.000198	0.000394	CcSEcCtD
Zonisamide—Cough—Doxorubicin—ovarian cancer	0.000197	0.000392	CcSEcCtD
Zonisamide—Shock—Epirubicin—ovarian cancer	0.000196	0.00039	CcSEcCtD
Zonisamide—Convulsion—Doxorubicin—ovarian cancer	0.000196	0.000389	CcSEcCtD
Zonisamide—Nervous system disorder—Epirubicin—ovarian cancer	0.000195	0.000389	CcSEcCtD
Zonisamide—Dizziness—Docetaxel—ovarian cancer	0.000195	0.000388	CcSEcCtD
Zonisamide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000195	0.000388	CcSEcCtD
Zonisamide—Hypertension—Doxorubicin—ovarian cancer	0.000195	0.000388	CcSEcCtD
Zonisamide—Tachycardia—Epirubicin—ovarian cancer	0.000194	0.000387	CcSEcCtD
Zonisamide—Skin disorder—Epirubicin—ovarian cancer	0.000193	0.000385	CcSEcCtD
Zonisamide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000192	0.000383	CcSEcCtD
Zonisamide—Myalgia—Doxorubicin—ovarian cancer	0.000192	0.000382	CcSEcCtD
Zonisamide—Chest pain—Doxorubicin—ovarian cancer	0.000192	0.000382	CcSEcCtD
Zonisamide—Arthralgia—Doxorubicin—ovarian cancer	0.000192	0.000382	CcSEcCtD
Zonisamide—Anxiety—Doxorubicin—ovarian cancer	0.000191	0.000381	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000191	0.00038	CcSEcCtD
Zonisamide—Discomfort—Doxorubicin—ovarian cancer	0.00019	0.000378	CcSEcCtD
Zonisamide—Anorexia—Epirubicin—ovarian cancer	0.00019	0.000378	CcSEcCtD
Zonisamide—Dry mouth—Doxorubicin—ovarian cancer	0.000188	0.000374	CcSEcCtD
Zonisamide—Vomiting—Docetaxel—ovarian cancer	0.000188	0.000373	CcSEcCtD
Zonisamide—Rash—Docetaxel—ovarian cancer	0.000186	0.00037	CcSEcCtD
Zonisamide—Hypotension—Epirubicin—ovarian cancer	0.000186	0.00037	CcSEcCtD
Zonisamide—Dermatitis—Docetaxel—ovarian cancer	0.000186	0.00037	CcSEcCtD
Zonisamide—Confusional state—Doxorubicin—ovarian cancer	0.000186	0.00037	CcSEcCtD
Zonisamide—Headache—Docetaxel—ovarian cancer	0.000185	0.000368	CcSEcCtD
Zonisamide—Oedema—Doxorubicin—ovarian cancer	0.000184	0.000367	CcSEcCtD
Zonisamide—Infection—Doxorubicin—ovarian cancer	0.000183	0.000364	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000181	0.000361	CcSEcCtD
Zonisamide—Shock—Doxorubicin—ovarian cancer	0.000181	0.000361	CcSEcCtD
Zonisamide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000181	0.00036	CcSEcCtD
Zonisamide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00018	0.000359	CcSEcCtD
Zonisamide—Insomnia—Epirubicin—ovarian cancer	0.00018	0.000358	CcSEcCtD
Zonisamide—Tachycardia—Doxorubicin—ovarian cancer	0.00018	0.000358	CcSEcCtD
Zonisamide—Skin disorder—Doxorubicin—ovarian cancer	0.000179	0.000356	CcSEcCtD
Zonisamide—Paraesthesia—Epirubicin—ovarian cancer	0.000179	0.000356	CcSEcCtD
Zonisamide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000178	0.000354	CcSEcCtD
Zonisamide—Dyspnoea—Epirubicin—ovarian cancer	0.000177	0.000353	CcSEcCtD
Zonisamide—Somnolence—Epirubicin—ovarian cancer	0.000177	0.000352	CcSEcCtD
Zonisamide—Anorexia—Doxorubicin—ovarian cancer	0.000176	0.000349	CcSEcCtD
Zonisamide—Nausea—Docetaxel—ovarian cancer	0.000175	0.000349	CcSEcCtD
Zonisamide—Dyspepsia—Epirubicin—ovarian cancer	0.000175	0.000349	CcSEcCtD
Zonisamide—Decreased appetite—Epirubicin—ovarian cancer	0.000173	0.000344	CcSEcCtD
Zonisamide—Hypotension—Doxorubicin—ovarian cancer	0.000172	0.000343	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000172	0.000342	CcSEcCtD
Zonisamide—Fatigue—Epirubicin—ovarian cancer	0.000172	0.000342	CcSEcCtD
Zonisamide—Constipation—Epirubicin—ovarian cancer	0.00017	0.000339	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000168	0.000334	CcSEcCtD
Zonisamide—Insomnia—Doxorubicin—ovarian cancer	0.000167	0.000332	CcSEcCtD
Zonisamide—Paraesthesia—Doxorubicin—ovarian cancer	0.000165	0.000329	CcSEcCtD
Zonisamide—Dyspnoea—Doxorubicin—ovarian cancer	0.000164	0.000327	CcSEcCtD
Zonisamide—Feeling abnormal—Epirubicin—ovarian cancer	0.000164	0.000326	CcSEcCtD
Zonisamide—Somnolence—Doxorubicin—ovarian cancer	0.000164	0.000326	CcSEcCtD
Zonisamide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000163	0.000324	CcSEcCtD
Zonisamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000162	0.000323	CcSEcCtD
Zonisamide—Decreased appetite—Doxorubicin—ovarian cancer	0.00016	0.000319	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000159	0.000316	CcSEcCtD
Zonisamide—Fatigue—Doxorubicin—ovarian cancer	0.000159	0.000316	CcSEcCtD
Zonisamide—Urticaria—Epirubicin—ovarian cancer	0.000158	0.000315	CcSEcCtD
Zonisamide—Constipation—Doxorubicin—ovarian cancer	0.000157	0.000313	CcSEcCtD
Zonisamide—Abdominal pain—Epirubicin—ovarian cancer	0.000157	0.000313	CcSEcCtD
Zonisamide—Body temperature increased—Epirubicin—ovarian cancer	0.000157	0.000313	CcSEcCtD
Zonisamide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000152	0.000302	CcSEcCtD
Zonisamide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000151	0.0003	CcSEcCtD
Zonisamide—Hypersensitivity—Epirubicin—ovarian cancer	0.000147	0.000292	CcSEcCtD
Zonisamide—Urticaria—Doxorubicin—ovarian cancer	0.000146	0.000291	CcSEcCtD
Zonisamide—Body temperature increased—Doxorubicin—ovarian cancer	0.000146	0.00029	CcSEcCtD
Zonisamide—Abdominal pain—Doxorubicin—ovarian cancer	0.000146	0.00029	CcSEcCtD
Zonisamide—Asthenia—Epirubicin—ovarian cancer	0.000143	0.000284	CcSEcCtD
Zonisamide—Pruritus—Epirubicin—ovarian cancer	0.000141	0.00028	CcSEcCtD
Zonisamide—Diarrhoea—Epirubicin—ovarian cancer	0.000136	0.000271	CcSEcCtD
Zonisamide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000136	0.00027	CcSEcCtD
Zonisamide—Asthenia—Doxorubicin—ovarian cancer	0.000132	0.000263	CcSEcCtD
Zonisamide—Dizziness—Epirubicin—ovarian cancer	0.000132	0.000262	CcSEcCtD
Zonisamide—Pruritus—Doxorubicin—ovarian cancer	0.00013	0.000259	CcSEcCtD
Zonisamide—Vomiting—Epirubicin—ovarian cancer	0.000127	0.000252	CcSEcCtD
Zonisamide—Diarrhoea—Doxorubicin—ovarian cancer	0.000126	0.000251	CcSEcCtD
Zonisamide—Rash—Epirubicin—ovarian cancer	0.000125	0.00025	CcSEcCtD
Zonisamide—Dermatitis—Epirubicin—ovarian cancer	0.000125	0.00025	CcSEcCtD
Zonisamide—Headache—Epirubicin—ovarian cancer	0.000125	0.000248	CcSEcCtD
Zonisamide—Dizziness—Doxorubicin—ovarian cancer	0.000122	0.000242	CcSEcCtD
Zonisamide—Nausea—Epirubicin—ovarian cancer	0.000118	0.000235	CcSEcCtD
Zonisamide—Vomiting—Doxorubicin—ovarian cancer	0.000117	0.000233	CcSEcCtD
Zonisamide—Rash—Doxorubicin—ovarian cancer	0.000116	0.000231	CcSEcCtD
Zonisamide—Dermatitis—Doxorubicin—ovarian cancer	0.000116	0.000231	CcSEcCtD
Zonisamide—Headache—Doxorubicin—ovarian cancer	0.000115	0.00023	CcSEcCtD
Zonisamide—Nausea—Doxorubicin—ovarian cancer	0.000109	0.000218	CcSEcCtD
Zonisamide—SCN4A—Developmental Biology—MAPK3—ovarian cancer	6.12e-05	0.000296	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK3—ovarian cancer	6.12e-05	0.000296	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—KRAS—ovarian cancer	6.09e-05	0.000295	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—AKT1—ovarian cancer	6.07e-05	0.000294	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—NRAS—ovarian cancer	6.07e-05	0.000293	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—MAPK1—ovarian cancer	6.06e-05	0.000293	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—EGFR—ovarian cancer	6.06e-05	0.000293	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—ovarian cancer	6.05e-05	0.000293	CbGpPWpGaD
Zonisamide—CA4—Metabolism—ABCB1—ovarian cancer	6.05e-05	0.000293	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC5A5—ovarian cancer	6.05e-05	0.000292	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—ovarian cancer	6.04e-05	0.000292	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CAV1—ovarian cancer	6.01e-05	0.000291	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PPP2R1A—ovarian cancer	5.99e-05	0.00029	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—KRAS—ovarian cancer	5.98e-05	0.000289	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TYMS—ovarian cancer	5.94e-05	0.000288	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1B1—ovarian cancer	5.94e-05	0.000287	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NME2—ovarian cancer	5.93e-05	0.000287	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CG—ovarian cancer	5.91e-05	0.000286	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CG—ovarian cancer	5.91e-05	0.000286	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK3—ovarian cancer	5.9e-05	0.000285	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PPP2R1A—ovarian cancer	5.88e-05	0.000284	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	5.85e-05	0.000283	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC2A1—ovarian cancer	5.84e-05	0.000282	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—MAPK1—ovarian cancer	5.82e-05	0.000282	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—MAPK1—ovarian cancer	5.82e-05	0.000282	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—EGFR—ovarian cancer	5.82e-05	0.000281	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—EGFR—ovarian cancer	5.82e-05	0.000281	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.82e-05	0.000281	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK3—ovarian cancer	5.81e-05	0.000281	CbGpPWpGaD
Zonisamide—CA2—Metabolism—ABCB1—ovarian cancer	5.8e-05	0.000281	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	5.77e-05	0.000279	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—KRAS—ovarian cancer	5.72e-05	0.000277	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CD—ovarian cancer	5.71e-05	0.000276	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TYMS—ovarian cancer	5.7e-05	0.000276	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—ERBB2—ovarian cancer	5.69e-05	0.000275	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—MAPK1—ovarian cancer	5.61e-05	0.000271	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—EGFR—ovarian cancer	5.61e-05	0.000271	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1B1—ovarian cancer	5.6e-05	0.000271	CbGpPWpGaD
Zonisamide—AOX1—Disease—TERT—ovarian cancer	5.57e-05	0.00027	CbGpPWpGaD
Zonisamide—CA1—Metabolism—ABCB1—ovarian cancer	5.56e-05	0.000269	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CD—ovarian cancer	5.56e-05	0.000269	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CD—ovarian cancer	5.56e-05	0.000269	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—MAPK1—ovarian cancer	5.53e-05	0.000267	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—EGFR—ovarian cancer	5.53e-05	0.000267	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—KRAS—ovarian cancer	5.5e-05	0.000266	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—KRAS—ovarian cancer	5.5e-05	0.000266	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CG—ovarian cancer	5.47e-05	0.000265	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TYMS—ovarian cancer	5.46e-05	0.000264	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—ABCB1—ovarian cancer	5.46e-05	0.000264	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—ovarian cancer	5.45e-05	0.000264	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TYMS—ovarian cancer	5.36e-05	0.000259	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—HRAS—ovarian cancer	5.35e-05	0.000259	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—KRAS—ovarian cancer	5.3e-05	0.000256	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PPP2R1A—ovarian cancer	5.27e-05	0.000255	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—KRAS—ovarian cancer	5.22e-05	0.000253	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CD—ovarian cancer	5.19e-05	0.000251	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CD—ovarian cancer	5.19e-05	0.000251	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—HRAS—ovarian cancer	5.18e-05	0.00025	CbGpPWpGaD
Zonisamide—AOX1—Disease—CAV1—ovarian cancer	5.16e-05	0.000249	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—ovarian cancer	5.12e-05	0.000247	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—HRAS—ovarian cancer	5.08e-05	0.000246	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.03e-05	0.000243	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—CTNNB1—ovarian cancer	4.98e-05	0.000241	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CB—ovarian cancer	4.97e-05	0.000241	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PPP2R1A—ovarian cancer	4.96e-05	0.00024	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—ovarian cancer	4.95e-05	0.00024	CbGpPWpGaD
Zonisamide—CA9—Metabolism—ABCB1—ovarian cancer	4.89e-05	0.000237	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6ST—ovarian cancer	4.89e-05	0.000236	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MMP9—ovarian cancer	4.88e-05	0.000236	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—ovarian cancer	4.87e-05	0.000235	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—HRAS—ovarian cancer	4.86e-05	0.000235	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CB—ovarian cancer	4.85e-05	0.000234	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CB—ovarian cancer	4.85e-05	0.000234	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CD—ovarian cancer	4.81e-05	0.000233	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TYMS—ovarian cancer	4.8e-05	0.000232	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CAV1—ovarian cancer	4.79e-05	0.000232	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—YAP1—ovarian cancer	4.73e-05	0.000229	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—AKT1—ovarian cancer	4.72e-05	0.000228	CbGpPWpGaD
Zonisamide—CA3—Metabolism—PIK3CA—ovarian cancer	4.71e-05	0.000228	CbGpPWpGaD
Zonisamide—AOX1—Disease—APC—ovarian cancer	4.7e-05	0.000227	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—HRAS—ovarian cancer	4.67e-05	0.000226	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—HRAS—ovarian cancer	4.67e-05	0.000226	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.67e-05	0.000226	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—ovarian cancer	4.65e-05	0.000225	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—ABCB1—ovarian cancer	4.61e-05	0.000223	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CAV1—ovarian cancer	4.59e-05	0.000222	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—AKT1—ovarian cancer	4.57e-05	0.000221	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TYMS—ovarian cancer	4.53e-05	0.000219	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CB—ovarian cancer	4.53e-05	0.000219	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CB—ovarian cancer	4.53e-05	0.000219	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—HRAS—ovarian cancer	4.51e-05	0.000218	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—AKT1—ovarian cancer	4.49e-05	0.000217	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—ovarian cancer	4.47e-05	0.000216	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—ovarian cancer	4.47e-05	0.000216	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—MAPK1—ovarian cancer	4.46e-05	0.000216	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—HRAS—ovarian cancer	4.44e-05	0.000215	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CAV1—ovarian cancer	4.4e-05	0.000213	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—ovarian cancer	4.38e-05	0.000212	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CG—ovarian cancer	4.36e-05	0.000211	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—STAT3—ovarian cancer	4.34e-05	0.00021	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—NRAS—ovarian cancer	4.33e-05	0.000209	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CAV1—ovarian cancer	4.32e-05	0.000209	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—ovarian cancer	4.31e-05	0.000209	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PTEN—ovarian cancer	4.3e-05	0.000208	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—AKT1—ovarian cancer	4.29e-05	0.000208	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—ovarian cancer	4.25e-05	0.000206	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CB—ovarian cancer	4.19e-05	0.000203	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PTEN—ovarian cancer	4.19e-05	0.000203	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PTEN—ovarian cancer	4.19e-05	0.000203	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CG—ovarian cancer	4.18e-05	0.000202	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK3—ovarian cancer	4.15e-05	0.000201	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CD—ovarian cancer	4.13e-05	0.0002	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—AKT1—ovarian cancer	4.13e-05	0.0002	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—AKT1—ovarian cancer	4.13e-05	0.0002	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.1e-05	0.000198	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CG—ovarian cancer	4.01e-05	0.000194	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—AKT1—ovarian cancer	3.98e-05	0.000192	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—MAPK1—ovarian cancer	3.95e-05	0.000191	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—EGFR—ovarian cancer	3.94e-05	0.000191	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CG—ovarian cancer	3.93e-05	0.00019	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PTEN—ovarian cancer	3.91e-05	0.000189	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PTEN—ovarian cancer	3.91e-05	0.000189	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CAV1—ovarian cancer	3.87e-05	0.000187	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—FASN—ovarian cancer	3.86e-05	0.000187	CbGpPWpGaD
Zonisamide—CA3—Metabolism—AKT1—ovarian cancer	3.84e-05	0.000186	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CD—ovarian cancer	3.84e-05	0.000186	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYTB—ovarian cancer	3.82e-05	0.000185	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC5A5—ovarian cancer	3.79e-05	0.000184	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.73e-05	0.000181	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—KRAS—ovarian cancer	3.73e-05	0.00018	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CD—ovarian cancer	3.68e-05	0.000178	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC2A1—ovarian cancer	3.66e-05	0.000177	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CAV1—ovarian cancer	3.65e-05	0.000176	CbGpPWpGaD
Zonisamide—AOX1—Disease—ERBB2—ovarian cancer	3.65e-05	0.000176	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PTEN—ovarian cancer	3.62e-05	0.000175	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTOR—ovarian cancer	3.6e-05	0.000174	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CB—ovarian cancer	3.6e-05	0.000174	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—HRAS—ovarian cancer	3.58e-05	0.000173	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NME2—ovarian cancer	3.56e-05	0.000172	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CG—ovarian cancer	3.53e-05	0.000171	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CD—ovarian cancer	3.53e-05	0.000171	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1B1—ovarian cancer	3.51e-05	0.00017	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CD—ovarian cancer	3.46e-05	0.000167	CbGpPWpGaD
Zonisamide—AOX1—Disease—CDKN1B—ovarian cancer	3.38e-05	0.000163	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CB—ovarian cancer	3.34e-05	0.000162	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—BRIP1—ovarian cancer	3.34e-05	0.000162	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPP1CC—ovarian cancer	3.34e-05	0.000162	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CG—ovarian cancer	3.32e-05	0.000161	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CB—ovarian cancer	3.21e-05	0.000155	CbGpPWpGaD
Zonisamide—AOX1—Disease—CTNNB1—ovarian cancer	3.19e-05	0.000154	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—HRAS—ovarian cancer	3.17e-05	0.000153	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPP2R1A—ovarian cancer	3.12e-05	0.000151	CbGpPWpGaD
Zonisamide—AOX1—Disease—PTEN—ovarian cancer	3.11e-05	0.00015	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CD—ovarian cancer	3.1e-05	0.00015	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CB—ovarian cancer	3.07e-05	0.000149	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PIK3CA—ovarian cancer	3.03e-05	0.000147	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—ovarian cancer	3.03e-05	0.000147	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CB—ovarian cancer	3.01e-05	0.000146	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PIK3CA—ovarian cancer	2.95e-05	0.000143	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PIK3CA—ovarian cancer	2.95e-05	0.000143	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CD—ovarian cancer	2.92e-05	0.000141	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—ABCB1—ovarian cancer	2.89e-05	0.00014	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PTEN—ovarian cancer	2.89e-05	0.00014	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TYMS—ovarian cancer	2.84e-05	0.000137	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT1—ovarian cancer	2.8e-05	0.000135	CbGpPWpGaD
Zonisamide—AOX1—Disease—STAT3—ovarian cancer	2.78e-05	0.000135	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRAS—ovarian cancer	2.77e-05	0.000134	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PTEN—ovarian cancer	2.77e-05	0.000134	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PIK3CA—ovarian cancer	2.76e-05	0.000133	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PIK3CA—ovarian cancer	2.76e-05	0.000133	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CB—ovarian cancer	2.7e-05	0.000131	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK3—ovarian cancer	2.66e-05	0.000129	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PTEN—ovarian cancer	2.66e-05	0.000128	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PTEN—ovarian cancer	2.6e-05	0.000126	CbGpPWpGaD
Zonisamide—AOX1—Disease—MYC—ovarian cancer	2.58e-05	0.000125	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PIK3CA—ovarian cancer	2.56e-05	0.000124	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CB—ovarian cancer	2.55e-05	0.000123	CbGpPWpGaD
Zonisamide—AOX1—Disease—MAPK1—ovarian cancer	2.53e-05	0.000122	CbGpPWpGaD
Zonisamide—AOX1—Disease—EGFR—ovarian cancer	2.53e-05	0.000122	CbGpPWpGaD
Zonisamide—CA14—Metabolism—AKT1—ovarian cancer	2.48e-05	0.00012	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.43e-05	0.000118	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—AKT1—ovarian cancer	2.41e-05	0.000117	CbGpPWpGaD
Zonisamide—CA6—Metabolism—AKT1—ovarian cancer	2.41e-05	0.000117	CbGpPWpGaD
Zonisamide—AOX1—Disease—KRAS—ovarian cancer	2.39e-05	0.000116	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PTEN—ovarian cancer	2.33e-05	0.000113	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYTB—ovarian cancer	2.3e-05	0.000111	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CAV1—ovarian cancer	2.29e-05	0.000111	CbGpPWpGaD
Zonisamide—CA7—Metabolism—AKT1—ovarian cancer	2.25e-05	0.000109	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—AKT1—ovarian cancer	2.25e-05	0.000109	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—YAP1—ovarian cancer	2.24e-05	0.000108	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.22e-05	0.000107	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PTEN—ovarian cancer	2.2e-05	0.000106	CbGpPWpGaD
Zonisamide—AOX1—Disease—PIK3CA—ovarian cancer	2.19e-05	0.000106	CbGpPWpGaD
Zonisamide—CA12—Metabolism—AKT1—ovarian cancer	2.09e-05	0.000101	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CG—ovarian cancer	2.09e-05	0.000101	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PIK3CA—ovarian cancer	2.04e-05	9.86e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—HRAS—ovarian cancer	2.03e-05	9.82e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.01e-05	9.71e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.01e-05	9.71e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PIK3CA—ovarian cancer	1.95e-05	9.45e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.95e-05	9.42e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—ovarian cancer	1.94e-05	9.4e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PIK3CA—ovarian cancer	1.87e-05	9.06e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PIK3CA—ovarian cancer	1.84e-05	8.89e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CD—ovarian cancer	1.83e-05	8.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—FASN—ovarian cancer	1.83e-05	8.83e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.8e-05	8.69e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT1—ovarian cancer	1.79e-05	8.67e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.73e-05	8.39e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.7e-05	8.21e-05	CbGpPWpGaD
Zonisamide—CA4—Metabolism—AKT1—ovarian cancer	1.66e-05	8.05e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.66e-05	8.04e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PIK3CA—ovarian cancer	1.65e-05	7.97e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CB—ovarian cancer	1.6e-05	7.73e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—AKT1—ovarian cancer	1.6e-05	7.72e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PIK3CA—ovarian cancer	1.55e-05	7.51e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—AKT1—ovarian cancer	1.53e-05	7.4e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—AKT1—ovarian cancer	1.5e-05	7.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.47e-05	7.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.47e-05	7.1e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PTEN—ovarian cancer	1.38e-05	6.68e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.37e-05	6.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—YAP1—ovarian cancer	1.35e-05	6.51e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKT1—ovarian cancer	1.35e-05	6.51e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TYMS—ovarian cancer	1.34e-05	6.51e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKT1—ovarian cancer	1.27e-05	6.13e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—FASN—ovarian cancer	1.1e-05	5.31e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CAV1—ovarian cancer	1.08e-05	5.24e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.08e-05	5.22e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.04e-05	5.04e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.04e-05	5.01e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1e-05	4.84e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CG—ovarian cancer	9.87e-06	4.77e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PIK3CA—ovarian cancer	9.74e-06	4.71e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	8.87e-06	4.29e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CD—ovarian cancer	8.68e-06	4.2e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.23e-06	3.98e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TYMS—ovarian cancer	8.09e-06	3.91e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKT1—ovarian cancer	7.96e-06	3.85e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CB—ovarian cancer	7.56e-06	3.66e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PTEN—ovarian cancer	6.53e-06	3.16e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CAV1—ovarian cancer	6.52e-06	3.15e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.93e-06	2.87e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.22e-06	2.52e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PIK3CA—ovarian cancer	4.61e-06	2.23e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.55e-06	2.2e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PTEN—ovarian cancer	3.93e-06	1.9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKT1—ovarian cancer	3.77e-06	1.82e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.77e-06	1.34e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKT1—ovarian cancer	2.26e-06	1.1e-05	CbGpPWpGaD
